Cervical cancer (CC) is one of the leading causes of death in women due to cancer and a
major concern in the developing world. Persistent human papilloma virus (HPV) infection is …

Cervical cancer (CC) is the primary cause of cancer deaths in underdeveloped countries.
The persistence of infection with high-risk human papillomavirus (HPV) is a significant …

Cervical cancer (CC) is the third most diagnosed cancer among females worldwide and the
fourth cause of cancer‑related mortality. Prophylactic HPV vaccines and traditional pap …

MicroRNAs (miRNAs) have become the center of interest in oncology. In recent years,
various studies have demonstrated that miRNAs regulate gene expression by influencing …

Human papillomaviruses (HPV) infection is a major causative agent and strongly associated
with the development of cervical cancer. Understanding the mechanisms of HPV-induced …

Cervical cancer (CC) is one of the most common malignancies affecting women worldwide.
While the morbidity and mortality associated with CC are decreasing in western countries …

Cervical cancer is the leading cause of death by cancer in women from developing
countries. Persistent infection with high-risk human papillomavirus (HPV) types 16 and 18 is …

MicroRNAs (miRNAs) are a class of small non coding RNAs of 18–25 nucleotides in length.
The temporal or short‐lived expression of the miRNAs modulates gene expression post …

Cervical cancer is the fourth leading cause of cancer-related death among women
worldwide. The chemotherapeutical agent cisplatin, a small platinum-based compound, is …

Cervical carcinoma (CC) is one of the most common cancers and a leading cause of
mortality in women worldwide. Epidemiologic and experimental data have clearly …